- ACHIEVE Group - Life-Scienced Bites!
- Posts
- Life-Scienced Bites - January 2025
Life-Scienced Bites - January 2025
Highlights of the happenings and developments in Life Science.
Ahmed Khalil Khan | Consulting Manager | [email protected] | +65 9675 38 14

Happy Lunar New Year!
Wishing you prosperity, joy, and a blessed year ahead!
Welcome aboard our inaugural
Life-Scienced Bites!
This is our monthly newsletter for our valued network of talents and clients where we hope to provide some highlights into the developments in the Life Science industry for the month as well as updates to our team here at ACHIEVE Group.
Here are the topics for the month!
ACHIEVE Group - Life Science Division
Business Highlights
Star talents
ACHIEVE Group - Life Science Division
The workspace industry constantly evolves, mirroring the rise and fall of emerging industries, trends, and businesses. At ACHIEVE, our 34 years of experience in the talent industry have taught us the importance of embracing change and adapting to stay ahead.
Thus, we are excited to introduce our newest division - the Life Sciences Division!

Ahmed Khalil Khan (left), Nura Mohd Noor (centre), Xianjin Chen (right).
The Life Sciences Division will be our key experts in connecting our best talent with the best opportunity. Our team is headed by Nura Mohd Noor, who brings an impressive 17 years of talent acquisition expertise! Over the years, she has honed an exceptional ability to uncover hidden gems, ensuring they’re placed in the right environment to truly thrive. With her extensive network and remarkable approachability, Nura is an invaluable asset. Don’t hesitate to connect with her and discover how we can elevate your hiring strategies to new heights
Accompanying her, Xianjin Chen and Ahmed Khalil Khan are two brilliant individuals who hail from the Life Science industry and have a wealth of technical expertise and industry knowledge.
Together, the Life Science Division, aptly named SuperNova, aim to bring an explosive and energetic approach to Talent Acquisition. We invite you to connect with us and together, we will light the way!
Business Highlights
The start of a new year is an exciting chapter for any industry—a time to embrace growth, forge new partnerships, and explore fresh opportunities. It’s also a valuable moment to reflect on the past year, reassess achievements, realign strategies, and rediscover our goals with renewed focus and determination.
The biggest MedTech M&A deals of 2024: With a combined value of $26B, these 5 deals show that the MedTech industry is still definitely alive and kicking! Read more here. Apart from showcasing who’s the who in the industry, M&A deals also shed light on the key sectors that are gaining traction in the industry. 2024 saw more than a 100% increase in the number of M&A transactions in 2023, showing that the industry is becoming more agile and a lot of movement can be anticipated in the future. For a more comprehensive insight, here’s a 2024 MedTech report by J.P. Morgan.
$500B investment in AI infrastructure announced: AI is a buzzword thrown around everywhere and it is rightly so. Paving the way for a more AI-integrated future, the new U.S. President announced a $500B investment in AI infrastructure, read more here. This would have direct implications on how AI can be further developed for drug-discovery applications, disease diagnosis and many more. It is certainly a sector to keep your eyes on.
Singapore’s biotechnology scene: In 2000, the Singapore government chartered a goal to make biomedical research a pillar of the economy. Now in 2025, Singapore has established itself as the leading hub in the APAC region. A healthy infrastructure has attracted the likes of giants like Johnson & Johnson for the past 50 years, and also as fertile ground for burgeoning startups. Read here for more information on the 7 biotech companies leading the way in 2025.
Star Talents
Don’t underestimate being new as being unprepared! The Life Science division is always on the lookout to furnish their roster with the cream of the crop. Here, we highlight some of the star talents in our pool who are passively and actively looking for new opportunities.
If you are looking for top-notch individuals to join your team, let us know and we can discuss how we can bring such talents to you!
ACLS1002501 | Marketing Director | Circa $240,000
Medical Devices & Healthcare | Commercial & Marketing
Singapore | March onwards
ACLS1002502 | Scientific Director/Lead Scientist | Circa $180,000
Food, Nutrition & Microbiology | R&D
Open to relocate | Immediate
ACLS1002503 | Regional Medical Director | Circa $200,000
Oncology & Early Pipeline | Strategy & Innovation
Singapore | Immediate
ACLS1002504 | Medical Affairs & Clinical Leader | Circa $250,000
Pharmaceuticals & Medical Devices | Global Strategy & R&D
Singapore | Immediate
ACLS1002505 | Business Unit Director | Circa $280,000
Biotechnology | Channel Partnerships
Open to relocate | Immediate
ACLS1002506 | Head of Marketing | Circa $180,000
Biomanufacturing | Marketing Strategy
Open to relocate | Immediate
ACLS1002507 | Head of Marketing | Circa $180,000
Aesthetics & Pharmaceuticals | Marketing Strategy
Open to relocate | Immediate
ACLS1002508 | Regional Commercial Director | Circa $300,000
FMCG & MedTech & Specialty Pharmaceuticals | Commercial & Marketing Strategy
Open to relocate | Immediate
ACLS1002509 | APAC Innovation Lead | Circa $230,000
Food & Nutrition & Health Technology | Strategy, Innovation | Business Partnerships
Singapore | Immediate
ACLS1002510 | Head of Supply Chain | Circa $230,000
Pharmaceuticals | Global Supply Chain & Commercial Strategy
Singapore | Immediate
Contact Us: [email protected]
Mobile: +65 9116 7743 Office: +65 6590 9942
Have a free copy of our 2025 Salary Guide, please make a request here.

